Effects of supplementing with Saccharomyces boulardii on vonoprazan–amoxicillin dual therapy for naive Helicobacter pylori infection: a randomized controlled trial

Abstract Background and aims This randomized controlled trial (RCT) sought to investigate whether Saccharomyces boulardii (S. boulardii) can improve the Helicobacter pylori (H. pylori) eradication rate and reduce adverse events when added to the vonoprazan–amoxicillin dual therapy—a first-line treat...

Descripció completa

Dades bibliogràfiques

Autors principals:	Zexuan Ji, Dingni Qu, Yonghao Feng, Xiangrong Qin, Xiaoyong Wang
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2026-04-01
Col·lecció:	BMC Gastroenterology
Matèries:	Helicobacter pylori Saccharomyces boulardii Vonoprazan Dual therapy Randomized controlled trial
Accés en línia:	https://doi.org/10.1186/s12876-026-04865-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!